Abstract:Traditional Chinese Medicine fosters a dynamic balance within bone homeostasis via its sophisticated modulation of the immune system. The finesse of TCM's regulatory mechanisms resides in their capacity to delicately calibrate immune responses, thus attenuating pro‐inflammatory cascades and simultaneously enhancing regenerative processes that prioritize osteogenesis over bone resorption. Osteoporosis (OP) is a globally prevalent bone disease characterized by reduced bone mass and heightened fracture risk, posing a significant health and economic challenge to aging societies worldwide. Osteoimmunology—an emerging field of study—investigates the intricate relationship between the skeletal and the immune systems, providing insights into the immune system's impact on bone health and disease progression. Recent research has demonstrated the essential roles played by various immune cells (T cells, B cells, macrophages, dendritic cells, mast cells, granulocytes, and innate lymphoid cells) in regulating bone metabolism, homeostasis, formation, and remodeling through interactions with osteoclasts (OC) and osteoblasts (OB). These findings underscore that osteoimmunology provides an essential theoretical framework for understanding the pathogenesis of various skeletal disorders, including OP. Traditional Chinese medicine (TCM) and its active ingredients have significant clinical value in OP treatment. Unfortunately, despite their striking multieffect pathways in the pharmacological field, current research has not yet summarized them in a comprehensive and detailed manner with respect to their interventional roles in immune bone diseases, especially OP. Consequently, this review addresses recent studies on the mechanisms by which immune cells and their communication molecules contribute to OP development. Additionally, it explores the potential therapeutic benefits of TCM and its active components in treating OP from the perspective of osteoimmunology. The objective is to provide a comprehensive framework that enhances the understanding of the therapeutic mechanisms of TCM in treating immune‐related bone diseases and to facilitate the development of novel therapeutic strategies.

Osteoimmunology: The correlation between osteoclasts and the Th17/Treg balance in osteoporosis

Type 17 T-helper Cells Might Be a Promising Therapeutic Target for Osteoporosis.

Correlation Between Osteoporosis and Osteoclast Differentiation and Activation

Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases

Regulatory T cells as a potent target for controlling bone loss.

The Nexus Between Traditional Chinese Medicine and Immunoporosis: Implications in the Treatment and Management of Osteoporosis

The Role of T Cells in Osteoporosis, an Update.

Exercise and osteoimmunology in bone remodeling

The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance

The Interplay between Immune System and Microbiota in Osteoporosis

The Imbalance of Cytokines and Lower Levels of Tregs in Elderly Male Primary Osteoporosis

[Research progress on the role of regulatory T cells/Th17 cells balance in muscle-bone degeneration and reconstruction]

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review

Cytokines: The links between bone and the immune system

Clinical immunity in bone and joints

The Th17/Treg cell balance: crosstalk among the immune system, bone and microbes in periodontitis.

Research and Application of Target Therapy for Osteoporosis

The balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering

OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism

Communication factors-promising targets in osteoporosis treatment.

Osteoblasts and Osteoclasts in Bone Remodeling and Inflammation